Biota and partner MedImmune begin antiviral trial for respiratory virus. [ + ]

Computer modelling uncovers protein function by sequence. [ + ]

Scientists investigating drug therapies for children with Acute Lymphoblastic Leukaemia (ALL) have presented new data demonstrating for the very first time that a small molecule called ABT-737 can increase the effectiveness of standard therapies.

Perth will be hosting a major epigenetics conference in November. [ + ]

Nominations for the 2008 ATSE Clunies Ross Awards, Australia’s awards for scientists, technologists and innovators, close on 31 July 2007.

University of Queensland-based contract research organisation TetraQ is now recognised to provide internationally accredited testing services to the Australian biopharmaceutical industry.

DNA polymerase epsilon has a critical role in DNA replication, researchers find. [ + ]

All Australian patents are now freely searchable. [ + ]

Mesenchymal tem cells taken from fat tissue used to treat colon cancer. [ + ]

Monash uni is the first organisation outside of Europe to be given associate membership of EMBL. [ + ]

Mass spectrometry expert appointed new CEO of the Australian Research Council. [ + ]

An ambitious international effort has been launched to decode the genome of Eucalyptus, one of the world's most valuable fibre- and paper-producing trees - with the goal to maximise its potential in the burgeoning bio energy market and for capturing excess atmospheric carbon.

Following a decision by the European Molecular Biology Laboratory (EMBL) Council, Australia is set to be granted Associate Membership of EMBL.

NIH-funded trial of Starpharma's VivaGel microbicide under way in US. [ + ]

$331 million deal sees Roche move into RNAi-based therapeutics. [ + ]